Serine/threonine kinase inhibitors
US9763942B2 · kind B2 · utility
5Cited by
5References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2016 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Aug 9, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.